Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Tallantyre

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2022
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: NoEmma C Tallantyre
Journal of Neurology|November 2, 2018
Nerve sheath tumoursJames A Robertson, Emma C Tallantyre
Practical Neurology|May 8, 2021
MRI: how to understand itClaire Louise MacIver, Sian Ebden, Emma C Tallantyre
Current Opinion in Allergy and Clinical Immunology|October 10, 2018
Secondary antibody deficiency in neurologyEmma C Tallantyre, Neil P Robertson, Stephen Jolles
Practical Neurology|November 13, 2015
How to run a multiple sclerosis relapse clinicEmma C Tallantyre, Mark Wardle, Neil P Robertson
JAMA Neurology|October 15, 2019
Cautious Interpretation of Observational Data-ReplyKatharine E Harding, Emma C Tallantyre, Neil P Robertson
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2026
A framework for blood biomarker discovery in MSEmma C Tallantyre, Sean Apap Mangion, Charlotte E Teunissen
Multiple Sclerosis and Related Disorders|January 23, 2022
Incidence of persistent lymphopenia in people with multiple sclerosis on dimethyl fumarateCallum H Wood, Neil P Robertson, Zin Min Htet, et al.
Journal of Neurology|May 22, 2025
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosisLaura Davies, Rasheed Shehadeh, W John Watkins, et al.
Archives of Neurology|August 12, 2009
Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutationEmma C Tallantyre, Simon M L Paine, Colin P Sharp, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2022
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: NoEmma C Tallantyre
Journal of Neurology|November 2, 2018
Nerve sheath tumoursJames A Robertson, Emma C Tallantyre
Practical Neurology|May 8, 2021
MRI: how to understand itClaire Louise MacIver, Sian Ebden, Emma C Tallantyre
Current Opinion in Allergy and Clinical Immunology|October 10, 2018
Secondary antibody deficiency in neurologyEmma C Tallantyre, Neil P Robertson, Stephen Jolles
Practical Neurology|November 13, 2015
How to run a multiple sclerosis relapse clinicEmma C Tallantyre, Mark Wardle, Neil P Robertson
JAMA Neurology|October 15, 2019
Cautious Interpretation of Observational Data-ReplyKatharine E Harding, Emma C Tallantyre, Neil P Robertson
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2026
A framework for blood biomarker discovery in MSEmma C Tallantyre, Sean Apap Mangion, Charlotte E Teunissen
Multiple Sclerosis and Related Disorders|January 23, 2022
Incidence of persistent lymphopenia in people with multiple sclerosis on dimethyl fumarateCallum H Wood, Neil P Robertson, Zin Min Htet, et al.
Journal of Neurology|May 22, 2025
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosisLaura Davies, Rasheed Shehadeh, W John Watkins, et al.
Archives of Neurology|August 12, 2009
Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutationEmma C Tallantyre, Simon M L Paine, Colin P Sharp, et al.
Pageof 5